Obermatt
See Similar Stocks →

Actuate Therapeutics

NMQ:ACTU · US0050831009
BiotechnologyX-Small

360° View

no current rank
Price/Sales—
Price/Earnings25
Price/Book89
Dividend Yield—
Revenue Growth—
Profit Growth98
Capital Growth9
TSR 52w1
Leverage28
Liquidity9
Refinancing9
Combined—
Analyst Opinions100
Pro Holdings13
Opinion Changes50
Market Pulse9

Profile

CountryUSA
IndustryBiotechnology
SizeX-Small
TypePublic Company
ExchangeNASDAQGM
Founded2015
Employees14
Websiteactuatetherapeutics.com
ISINUS0050831009
Last UpdateApr 2, 2026
Index & Theme
HematologyOncologyPharmaceutical

Description

Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company. Class-Leading GSK-3ß Inhibitor The company is focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen…

Similar Stocks

The companies this stock is ranked against.

Compare Actuate Therapeutics with its peers
Oncolytics Biotech
NAQ:ONCY
—
CountryCanada
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Zentalis Pharmaceuticals
NMQ:ZNTL
12
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Galectin Therapeutics
NAQ:GALT
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
ImageneBio
NAQ:IMA
22
CountryUSA
IndustryPharmaceuticals
SizeSmall
Full Stock Analysis →
Sagimet Biosciences
NMQ:SGMT
59
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mineralys Therapeutics
NSQ:MLYS
21
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →